- Home
- RS vs INAB Comparison
RS vs INAB Comparison
Compare RS & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RS
- INAB
- Stock Information
- Founded
- RS 1939
- INAB 2016
- Country
- RS United States
- INAB United States
- Employees
- RS N/A
- INAB N/A
- Industry
- RS Metal Fabrications
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- RS Industrials
- INAB Health Care
- Exchange
- RS Nasdaq
- INAB Nasdaq
- Market Cap
- RS 16.5B
- INAB 14.5M
- IPO Year
- RS 1994
- INAB 2021
- Fundamental
- Price
- RS $328.97
- INAB $2.30
- Analyst Decision
- RS Hold
- INAB Strong Buy
- Analyst Count
- RS 4
- INAB 2
- Target Price
- RS $332.67
- INAB $108.00
- AVG Volume (30 Days)
- RS 354.3K
- INAB 170.0K
- Earning Date
- RS 07-23-2025
- INAB 08-07-2025
- Dividend Yield
- RS 1.46%
- INAB N/A
- EPS Growth
- RS N/A
- INAB N/A
- EPS
- RS 14.01
- INAB N/A
- Revenue
- RS $13,674,900,000.00
- INAB N/A
- Revenue This Year
- RS $4.80
- INAB N/A
- Revenue Next Year
- RS $4.71
- INAB N/A
- P/E Ratio
- RS $23.45
- INAB N/A
- Revenue Growth
- RS N/A
- INAB N/A
- 52 Week Low
- RS $250.07
- INAB $2.05
- 52 Week High
- RS $333.71
- INAB $27.30
- Technical
- Relative Strength Index (RSI)
- RS 64.07
- INAB 39.46
- Support Level
- RS $323.26
- INAB $2.10
- Resistance Level
- RS $333.71
- INAB $2.30
- Average True Range (ATR)
- RS 5.50
- INAB 0.14
- MACD
- RS 0.96
- INAB 0.11
- Stochastic Oscillator
- RS 76.85
- INAB 49.56
About RS Reliance Steel & Aluminum Co. (DE)
Reliance Inc is a diversified metal solutions provider and metals service center company. It provides value-added metals processing services and distributes.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.